Author + information
Little is known about the management of acute coronary syndromes (ACS) in developing countries, including Brazil. Our main purpose was the comparison between the results obtained by the Brazilian Registry of Acute Coronary syndromEs (BRACE) Registry, with data from other “BRIC” countries.
BRACE was a prospective multicenter registry that recruited ACS patients from 71 randomly selected hospitals in Brazil, stratified according to their regional location, complexity, teaching or non-teaching characteristics. For the overall population, the use of acetil salicylic acid (ASA), clopidogrel, ACE inhibitor/AT2 blocker, beta-blocker and statin during hospitalization was analyzed. Additionally, we analyzed the utilization of recanalization therapies (fibrinolytics and primary angioplasty) in the population with ST-elevation myocardial infarction (STEMI). The results were compared to published registries of other emerging countries – Russia (RECORD), India (CREATE) and China (CPACS). The Chi square test was applied for the developed comparisons.
1150 patients were enrolled in the BRACE. The mean age was 63.6 years, 733 (63.7%) were males, 25% had diabetes mellitus, 69.5% arterial hypertension, and 624 (54.2%) had STEMI. The comparisons of BRACE and other emerging countries’ registries are depicted on the table.
Despite the similarities among the BRIC countries, the management of ACS is significantly different between them.
|Reperfusion in STEMI (%)||64.9||34.9||66.5||51.6||<0.0001|
|Acetyl salicylic acid (ASA) (%)||92.2||97.1||NA||93.2||<0.0001|
|ASA or clopidogrel (%)||94.2||NA||97.9||NA||<0.0001|
|ACE inhibitors or ARB (%)||78.9||85.5||56.8||87.2||<0.0001|
Poster Sessions, Expo North
Saturday, March 09, 2013, 3:45 p.m.-4:30 p.m.
Session Title: AMI and PCI
Abstract Category: 28. Quality of Care and Outcomes Assessment
Presentation Number: 1158-102
- 2013 American College of Cardiology Foundation